Groovy Company pivots to blockchain as OTCM Protocol, launches Security Meme Tokens and Howey Shield

GROOVY COMPANY, INC.

Appointed Berge Abajian as CEO, Patrick Mokros as COO, Frank Yglesias as CTO; headquarters moved to Fairfield, NJ.
Launches Security Meme Tokens (SMTs) on Solana, backed 1:1 by preferred shares at Empire Stock Transfer, targeting 15,000+ OTC companies.
Files USPTO trademark #99420190 for 'Howey Shield' framework to ensure SMTs fail SEC's Howey Test and qualify as commodities.
Claims SMTs solve $50B OTC liquidity crisis with instant settlement, 24/7 trading, 0.5% transaction fee, and no dilution.

item 5.02 item 7.01 item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001499275-25-000005
form_type: 8-K
ticker: GROO
cik: 0001499275
company_name: GROOVY COMPANY, INC.
filed_at: 2025-10-02T23:59:59+00:00
discovered_at: 2026-05-14T18:02:39.565341+00:00
generated_at: 2026-05-17T04:55:33.159202+00:00
sec_items: ["5.02", "7.01", "8.01", "9.01"]
event_type: other_material
sentiment: positive
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001499275-25-000005
json_url: https://secwatch.observer/filing/0001499275-25-000005.json
markdown_url: https://secwatch.observer/filing/0001499275-25-000005.md
text_url: https://secwatch.observer/filing/0001499275-25-000005.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1499275/000149927525000005/0001499275-25-000005-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1499275/000149927525000005/groo-20250925_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

KRMN

Selling stockholders price upsized secondary offering of 14M shares at $61/share for ~$854M gross proceeds

Karman Holdings Inc. June 1, 2026, 5:28 PM ET other_material Items 1.01, 7.01, 8.01, 9.01

same SEC item: 7.01, 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

CSR

Centerspace approves $240-245M asset sales; exits Bismarck and Rapid City

CENTERSPACE June 1, 2026, 4:30 PM ET other_material Items 7.01, 8.01, 9.01

same SEC item: 7.01, 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

DGAC

Disciplined Growth Acquisition Corp. closes $150M IPO on NYSE

DISCIPLINED GROWTH ACQUISITION Corp June 1, 2026, 4:15 PM ET other_material Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01

same SEC item: 5.02, 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

IDYA

IDEAYA's darovasertib combo meets primary endpoint in Phase 2/3 OptimUM-02 trial for metastatic uveal melanoma

IDEAYA Biosciences, Inc. June 1, 2026, 4:05 PM ET other_material Items 7.01, 8.01, 9.01

same SEC item: 7.01, 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

DBX

Dropbox secures $400M revolving credit facility, authorizes $900M share repurchase program

DROPBOX, INC. June 1, 2026, 9:06 AM ET other_material Items 1.01, 2.03, 7.01, 8.01, 9.01

same SEC item: 7.01, 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

LIXT

Lixte Biotechnology pivots to AI energy infrastructure; appoints Denham Capital founder to board

LIXTE BIOTECHNOLOGY HOLDINGS, INC. June 1, 2026, 8:55 AM ET other_material Items 5.02, 7.01, 9.01

same SEC item: 5.02, 7.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

NXTC

NextCure Phase 1 SIM0505 data: 55% ORR in gynecologic cancers; cash into Q1 2027

NextCure, Inc. June 1, 2026, 8:10 AM ET other_material Items 7.01, 8.01, 9.01

same SEC item: 7.01, 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

JBIO

Jade Biosciences reports Phase 1 interim data: JADE101 shows ~70% IgA reduction, favorable safety, differentiated PK

Jade Biosciences, Inc. June 1, 2026, 7:55 AM ET other_material Items 7.01, 8.01, 9.01

same SEC item: 7.01, 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001499275-25-000005

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.